Marc Kaptein combines his former experience as a practicing physician with deep knowledge of research and development of innovative drugs and vaccines to ensure these innovations ultimately reach patients in need.
Marc studied medicine at the Vrije Universiteit Amsterdam. After graduating he practiced in the field of gynecology and obstetrics. He started his career in the pharmaceutical sector with Organon, a women’s health focused company, where he had various medical and marketing roles.
In 2007 he joined Eli Lilly and start-up MyTomorrows with ever-growing responsibilities. He started as Medical Director at Pfizer in 2016 where he currently holds the position of Sr. Director Policy&Public Affairs. Pfizer is a US based pharmaceutical company with 88.000 employees worldwide solely focused on developing innovative drugs and vaccines. Pfizer strives to bring breakthroughs to patients in the field of oncology, infectious diseases, auto-immune disease & inflammation, cardiovascular & metabolic disease.
During the corona crisis he played an instrumental role in the roll-out of Pfizer/BioNTech’s corona vaccine. In his capacity as senior medical voice of the pharmaceutical sector he aimed to reduce vaccination hesitancy by being a transparent source of knowledge about the development of vaccines, it’s safety and efficacy. Moreover he explained to the general public why patent protection, even in times of crisis, is preferred to ensure maximum worldwide vaccine manufacturing capacity.